Antifungals: use in high-risk patients.
Advanced medical technology has resulted in a growing population of patients with altered defense mechanisms against nosocomial infections. Fungal infections, primarily Candida species, account for a significant proportion of hospital-acquired infections and are associated with increased morbidity and mortality. This article discusses current issues and controversies related to nosocomial fungal infections and summarizes optimal management strategies.
Wright
J M
JM
University of Missouri at Kansas City, School of Medicine, USA.
D000935:Antifungal Agents / Q000627:therapeutic use*; D003422:Critical Care; D003428:Cross Infection / Q000188:drug therapy*; D006801:Humans
D000935:Antifungal Agents